Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ReposiTrak | TRAK | Nov 22, 2024 | 22.96 | +1.28 |
Republic Bancorp A | RBCAA | Nov 22, 2024 | 77.62 | +2.12 |
Republic Services | RSG | Nov 22, 2024 | 216.79 | +1.28 |
Research Frontiers | REFR | Nov 22, 2024 | 1.87 | -4.10 |
Research Solutions | RSSS | Nov 22, 2024 | 3.25 | +5.52 |
Reservoir Media | RSVR | Nov 22, 2024 | 9.43 | +4.89 |
ReShape Lifesciences | RSLS | Nov 22, 2024 | 5.55 | -0.54 |
Resideo Technologies | REZI | Nov 22, 2024 | 27.21 | +3.19 |
ResMed | RMD | Nov 22, 2024 | 243.78 | +0.07 |
Resources Connection | RGP | Nov 22, 2024 | 8.41 | +0.12 |
Restaurant Brands International | QSR | Nov 22, 2024 | 69.10 | -0.97 |
Retail Bull 3X Direxion | RETL | Nov 22, 2024 | 10.43 | +7.64 |
Retail ETF Market Vectors | RTH | Nov 22, 2024 | 224.62 | +0.89 |
Retail Opportunity Investments | ROIC | Nov 22, 2024 | 17.37 | -0.06 |
ReTo Eco-Solutions | RETO | Nov 22, 2024 | 0.95 | +4.38 |
Retractable Technologies | RVP | Nov 22, 2024 | 0.63 | +4.64 |
REV Group | REVG | Nov 22, 2024 | 30.91 | +3.66 |
Revance Therapeutics | RVNC | Nov 22, 2024 | 3.73 | -2.86 |
Revelation Biosciences | REVB | Nov 22, 2024 | 0.76 | +0.27 |
Revenueshares Largecap | RWL | Nov 22, 2024 | 103.10 | +0.76 |
Revenueshares Midcap | RWK | Nov 22, 2024 | 124.40 | +1.81 |
Revenueshares Smallcap | RWJ | Nov 22, 2024 | 48.29 | +1.77 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 22, 2024 | 52.23 | +0.96 |
Reviva Pharmaceuticals | RVPH | Nov 22, 2024 | 1.14 | -8.06 |
Revolution Medicines | RVMD | Nov 22, 2024 | 56.75 | -0.05 |
Revolve Group A | RVLV | Nov 22, 2024 | 35.02 | +0.57 |
Revvity | RVTY | Nov 22, 2024 | 112.03 | +0.83 |
REX American Resources | REX | Nov 22, 2024 | 45.45 | -0.20 |
Rexford Industrial Realty | REXR | Nov 22, 2024 | 42.08 | +0.26 |
Rexford Industrial Realty B Pref | REXR-B | Nov 22, 2024 | 22.76 | -1.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.